2022
DOI: 10.1016/j.fertnstert.2022.01.016
|View full text |Cite
|
Sign up to set email alerts
|

Long-term antimüllerian hormone patterns differ by cancer treatment exposures in young breast cancer survivors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 12 publications
(10 citation statements)
references
References 58 publications
0
10
0
Order By: Relevance
“…Next, detailing which specific cancer treatments, beyond broad categories of chemotherapy, radiation and surgery, are related to which maternal comorbidity is needed to prioritise research and clinical screening and surveillance. Future studies that leverage claims data to measure more detailed exposures may be feasible and valid 54–56 …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Next, detailing which specific cancer treatments, beyond broad categories of chemotherapy, radiation and surgery, are related to which maternal comorbidity is needed to prioritise research and clinical screening and surveillance. Future studies that leverage claims data to measure more detailed exposures may be feasible and valid 54–56 …”
Section: Discussionmentioning
confidence: 99%
“…Future studies that leverage claims data to measure more detailed exposures may be feasible and valid. [54][55][56]…”
Section: Discussionmentioning
confidence: 99%
“…27,30,31 Increased POI and decreased ovarian reserve have also been observed after platinum exposure in AYA cancer survivors. 25,32 More than 30 Gy radiation to the hypothalamus significantly increases risk of hypothalamic hypogonadism resulting in infertility from anovulation. 30 For the majority of additional chemotherapy and targeted therapy agents including immunotherapy, quality of evidence is less robust or absent.…”
Section: National Comprehensive Cancer Network 12mentioning
confidence: 99%
“…Some female CAYA survivors will have a residual but narrower window of ovarian function after cancer treatment. 28,32,38 Posttreatment FP via oocyte or embryo cryopreservation may be considered in those at risk of POI or infertility and never underwent FP before cancer treatment; survivors who underwent FP but may have insufficient cryopreserved materials for a reasonable chance at achieving their goal family size; and survivors who wish to defer childbearing and are thus at risk of age-related fertility decline.…”
Section: Post-treatment Considerations Femalesmentioning
confidence: 99%
See 1 more Smart Citation